Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

INTRODUCTION: This study examined the safety, tolerability, pharmacokinetics, and pharmacodynamics of empagliflozin, a potent and highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes mellitus (T2DM). METHODS: A total of 48 patients with T2DM were random...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Heise, Tim, Seman, Leo, Macha, Sreeraj, Jones, Peter, Marquart, Alexandra, Pinnetti, Sabine, Woerle, Hans J., Dugi, Klaus
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2013
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889329/
https://ncbi.nlm.nih.gov/pubmed/23838841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-013-0030-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky